Hutchison China MediTech logo

HCM - Hutchison China MediTech Share Price

340p -8.0  -2.3%

Last Trade - 13/12/19

Sector
Healthcare
Size
Mid Cap
Market Cap £2.27bn
Enterprise Value £2.11bn
Revenue £160.7m
Position in Universe 277th / 1841
Bullish
Bearish
Unlock HCM Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

HCM Revenue Unlock HCM Revenue

Net Income

HCM Net Income Unlock HCM Revenue

Normalised EPS

HCM Normalised EPS Unlock HCM Revenue

PE Ratio Range

HCM PE Ratio Range Unlock HCM Revenue

Dividend Yield Range

HCM Dividend Yield Range Unlock HCM Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2019
31st Dec 2020
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
HCM EPS Forecasts Unlock HCM Revenue
Profile Summary

Hutchison China Meditech Limited is an investment holding company principally engaged in the manufacture and sale of drugs. Along with subsidiaries, the Company operates its business through two segments. The Manufacturing Business segment is engaged in the manufacture and distribution of drug products. The Distribution Business segment provides sales and marketing services to pharmaceutical manufacturers. The Company's products include prescription and over the counter (OTC) pharmaceuticals such as banlangen, fu fang dan shen tablets and shexiang baoxin pills and others, and consumer health products. In addition, the Company also develops targeted therapeutics and immunotherapies for oncology and autoimmune diseases.

Directors
Last Annual December 31st, 2018
Last Interim June 30th, 2019
Incorporated December 18, 2000
Public Since May 19, 2006
No. of Shareholders: n/a
No. of Employees: 563
Sector Healthcare
Industry Pharmaceuticals
Index FTSE Aim All Share , FTSE Aim 100 ,
Exchange London Stock Exchange (AIM)
Shares in Issue 666,886,450
Free Float (0.0%)
Eligible for
ISAs
SIPPs
HCM Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for HCM
Upcoming Events for HCM
Thursday 23rd April, 2020 Estimate
Hutchison China MediTech Ltd Annual Shareholders Meeting
Similar to HCM
© Stockopedia 2019, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.